The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multicenter analysis of high-dose chemotherapy (HDCT) regimens for the treatment of patients (pts) with recurrent germ cell tumors (GCTs).
 
Alex Chehrazi-Raffle
Honoraria - ASCO; Medical Oncology Association of Southern California; OncLive/MJH Life Sciences
Consulting or Advisory Role - Aveo Inc; Exelixis; Seagen
Speakers' Bureau - Exelixis
Research Funding - Exelixis
Travel, Accommodations, Expenses - Bayer
 
Michael Olufemi Shodiya
No Relationships to Disclose
 
Edward Maldonado
No Relationships to Disclose
 
Tamer Othman
No Relationships to Disclose
 
Hedyeh Ebrahimi
No Relationships to Disclose
 
Regina Barragán Carrillo
No Relationships to Disclose
 
Xiaochen Li
No Relationships to Disclose
 
Adam Rock
Stock and Other Ownership Interests - Bristol Myers Squibb; Cigna; Merck
 
Abhishek Tripathi
Consulting or Advisory Role - AADi; Bayer; Deka Biosciences; Exelixis; Gilead Sciences; Seattle Genetics/Astellas
Speakers' Bureau - Sanofi
Research Funding - Aravive (Inst); Corvus Pharmaceuticals (Inst); EMD Serono (Inst)
 
Sumanta Kumar Pal
Travel, Accommodations, Expenses - crispr therapeutics; Exelixis; Ipsen
 
Tanya B. Dorff
Consulting or Advisory Role - AstraZeneca; Bayer; Exelixis; Janssen Oncology; Sanofi/Aventis
Research Funding - Pfizer (Inst)
 
Ali Zhumkhawala
No Relationships to Disclose
 
Rasmus Hoeg
No Relationships to Disclose
 
Caspian Oliai
No Relationships to Disclose
 
Rebecca L. Olin
Honoraria - Aptitude Health (I); Axiom Healthcare Strategies (I); Clarion Healthcare (I); Equinox Group (I)
Consulting or Advisory Role - Bayer (I); Bristol-Myers Squibb/Pfizer (I); Gilead Sciences (I); Janssen Oncology (I); Rigel; SERVIER
Research Funding - AstraZeneca (Inst); Cellectis (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst); Spectrum Pharmaceuticals (Inst); Takeda (Inst); Verastem (Inst)
 
Matthew Genyeh Mei
Honoraria - ADC Therapeutics; AstraZeneca; CTI; Novartis; Seagen
Speakers' Bureau - Incyte; Seagen
Research Funding - BeiGene (Inst); Celgene/Bristol-Myers Squibb (Inst); Incyte (Inst); MorphoSys (Inst)